Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.
about
Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice.Midkine: a promising molecule for drug development to treat diseases of the central nervous systemFrizzled-7 promoter is highly active in tumors and promoter-driven Shiga-like toxin I inhibits hepatocellular carcinoma growth.Midkine: a novel prognostic biomarker for cancer.Quantification of cellular and nuclear uptake rates of polymeric gene delivery nanoparticles and DNA plasmids via flow cytometry.Pancreatic cancer gene therapy: from molecular targets to delivery systems.
P2860
Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Midkine promoter-based conditi ...... ssing human pancreatic cancer.
@en
type
label
Midkine promoter-based conditi ...... ssing human pancreatic cancer.
@en
prefLabel
Midkine promoter-based conditi ...... ssing human pancreatic cancer.
@en
P2093
P2860
P356
P1476
Midkine promoter-based conditi ...... essing human pancreatic cancer
@en
P2093
Atsushi Kida
Daisuke Ito
Eiji Toyoda
Kazuhiro Kami
Kazuyuki Nagai
Masatoshi Tagawa
Masayuki Koizumi
Michihiko Wada
Shinji Uemoto
Tatsuo Ito
P2860
P2888
P356
10.1186/1756-9966-27-30
P577
2008-08-21T00:00:00Z
P5875
P6179
1045465693